

소개
Oral mucositis is a common, debilitating, and dose-limiting complication of chemotherapy and radiotherapy in head and neck cancer, profoundly affecting patients' quality of life and treatment compliance. Unplanned treatment interruptions due to mucositis can adversely influence therapeutic outcomes. Recent advances in understanding the integrated pathophysiology of radiation-induced mucosal injury have paved the way for the development of targeted preventive and therapeutic approaches.



